Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 161 participants.
Also called NCT01817699
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 161 participants
- Sponsor
- CANDLE-KIT Trial Study Group
- Registry
-
NCT01817699
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Terminated
Technical summary
Registry record NCT01817699. Randomized; no masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2018-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients
- Acronym
- CANDLE-KIT
- Condition
- Kidney Transplantation
- Condition
- Anemia
- Condition
- Vitamin D Deficiency
- Condition
- Renal Insufficiency, Chronic
- Intervention (Other)
- High Hb target
- Intervention (Dietary supplement)
- cholecalciferol
- Lead sponsor
- CANDLE-KIT Trial Study Group
- Collaborator
- Chugai Pharmaceutical
- Collaborator
- Japanese Society for the Promotion of Science
- Collaborator
- The Japan Kidney Foundation
- Collaborator
- Roche Diagnostics GmbH
Record details
- Record id
cardio:ct-nct01817699- Content hash
71fb232e4f62981e74259548c39cd57a78053246ba2b572936f197649e66044a